Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

135.75
+1.220.91%
Post-market: 134.72-1.0300-0.76%16:10 EDT
Volume:167.36K
Turnover:22.47M
Market Cap:57.02M
PE:- -
High:140.08
Open:135.54
Low:126.07
Close:134.53
52wk High:165.00
52wk Low:14.95
Shares:420.00K
Float Shares:420.00K
Volume Ratio:0.88
T/O Rate:39.85%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna to Present Late-Breaking Phase 3 Melanoma Data for Intismeran Autogene at ESMO 2026

Reuters
·
Sep 22

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 22

Moderna announces late-breaking data to be presented at ESMO Congress 2026

TIPRANKS
·
Sep 21

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

GlobeNewswire
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Moderna stock rises 8%: can it continue its cancer vaccine success rally?

Bellwether Stocks Movement
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Sep 18

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

TradingKey
·
Sep 18

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
Sep 18

Moderna Shares Hit Four-Week High; Last up 8%

THOMSON REUTERS
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Sep 17

Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million

Reuters
·
Sep 17